Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Colorectal Cancer, Genetics of clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Colorectal Cancer, Genetics of: 1 US clinical trial tracked, none currently recruiting.

Colorectal Cancer, Genetics of is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is University of Chicago, running 1 of these trials.

Enrollment posture brief

Registry condition colorectal-cancer-genetics-of

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Colorectal Cancer, Genet (th…0%
Open-enrollment share among volume-matched conditions near Colorectal Cancer, Genetics of

Colorectal Cancer, Genetics of has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colorectal Cancer, Genetics of on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colorectal Cancer, Genetics of is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Colorectal Cancer, Genetics of records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

prospective single arm biomarker (plasma cell-free DNA hydroxymethylation) study Diagnostic test
1 trials

US sites by state

Facility locations filed on Colorectal Cancer, Genetics of trials. A trial with sites in several states counts in each.

Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colorectal Cancer, Genetics of page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Colorectal Cancer, Genetics of trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • University of Chicago sponsors the most Colorectal Cancer, Genetics of trials on record, review their full trial history before evaluating a specific study. See University of Chicago's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Cancer, Genetics of condition card totals 1 registered trials; most-linked intervention prospective single arm biomarker (plasma cell-free DNA hydroxymethylation) study; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.